Cerea Partners and BNP Paribas Asset Management arranged unitranche debt financing for Naturacare's acquisition of Sochim International, enhancing Naturacare's position as a top European CDMO in dietary supplements.

Target Information

The Naturacare Group, headquartered in Montaigu-Vendée, is a leading Contract Development Manufacturing Organization (CDMO) specializing in the formulation and production of high-quality dietary supplements tailored to various needs, including vitamins and minerals, probiotics, aromatherapy, nutricosmetics, and sports nutrition. With five strategically located manufacturing sites across Europe in France, Belgium, the Netherlands, and Italy, Naturacare employs over 350 professionals and has achieved a revenue of nearly €100 million. Their diverse production capabilities encompass a comprehensive range of formulations such as capsules, tablets, granules, powders, liquid solutions, softgels, and gums.

Recently, Naturacare bolstered its market position by acquiring Sochim International, an Italian specialist in softgel manufacturing. This acquisition enhances Naturacare's competitive edge by incorporating unique expertise in producing softgels, which are complex to manufacture and primarily used for Omega 3 supplements, critical for human health. The Sochim site features advanced automation and substantial production capacity, adhering to the industry's highest standards, while also strengthening Naturacare's ingredient sourcing capabilities.

Industry Overview

In recent years, the European dietary supplements market has seen significant growth, driven by increasing health awareness and a rising demand for preventive health solutions. Italy, in particular, stands out as a key player in this sector, benefiting from a rich tradition in herbal an